FJARDE AP-FONDEN /FOURTH SWEDISH NATIONAL PENSION FUND 13D and 13G filings for Calliditas Therapeutics AB (publ):
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-01 4:55 pm Sale | 2022-12-31 | 13G | Calliditas Therapeutics AB (publ) CALT | FJARDE AP-FONDEN /FOURTH SWEDISH NATIONAL PENSION FUND | 2,663,000 4.500% | -12,000 (-0.45%) | Filing |
| 2022-02-14 4:06 pm Purchase | 2021-12-31 | 13G | Calliditas Therapeutics AB (publ) CALT | FJARDE AP-FONDEN /FOURTH SWEDISH NATIONAL PENSION FUND | 2,675,000 5.100% | 2,675,000 (New Position) | Filing |